| Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
|---|
| 04/30/2008 | EP1916240A1 Pyridazine derivatives |
| 04/30/2008 | EP1915369A1 Novel substituted 1,2,3-t ii azolylmethyl-benzothiophene or -indole and their use as leukotiiene biosynthesis inhibitors |
| 04/30/2008 | EP1915351A1 Quinazoline derivatives useful in cancer treatment |
| 04/30/2008 | EP1915345A1 Fluoro substituted 2-oxo azepan derivatives |
| 04/30/2008 | EP1601664B1 Biaryltetrahydroisoquinoline piperidines as selective mch receptor antagonists for the treatment of obesity and related disorders |
| 04/30/2008 | DE102006050512A1 New substituted dihydropyrazole- and dihydrotriazole derivatives are hypoxia-inducible transcription factor-prolyl-4-hydroxylase inhibitors useful to treat/prevent e.g. cardiovascular diseases, heart-circulation diseases and anemia |
| 04/30/2008 | CN101171248A 3-mono- and 3,5-disubstituted piperidine derivatives as renin inhibitors |
| 04/30/2008 | CN101171238A (3,4-dihydro-quinazolin-2-yl)-(2-aryloxy-ethyl)-amines having an activity on the 5-HT receptor |
| 04/30/2008 | CN101168533A Novel method for synthesizing chiral epoxy ketone |
| 04/30/2008 | CN100384837C Novel farnesyl protein transferase inhibitors as antitumor |
| 04/30/2008 | CN100384836C Novel cyclic amide derivatives |
| 04/30/2008 | CN100384825C Benzheterocyclic derivatives |
| 04/30/2008 | CN100384823C Bicyclic androgen and progesterone receptor modulator compounds and methods |
| 04/30/2008 | CN100384424C Synergistic methods and compositions for treating cancer |
| 04/29/2008 | US7365211 Heterocyclic GABAA subtype selective receptor modulators |
| 04/29/2008 | US7365196 Sulphonamido-substituted bridged bicycloalkyl derivatives |
| 04/29/2008 | US7365083 NMDA (N-methyl-D-aspartate) receptors; eg 6-(4-benzylpiperidin-1-carbonyl)-1,5-dihydro-oxazolo[4,5-f]indole-2-one |
| 04/29/2008 | US7365072 Inhibitors of p38 |
| 04/29/2008 | US7365070 Such as N-{2-[2-(5-Bromo-2-methoxy-phenyl)-ethyl]-3-fluoro-benzoyl}-N'-butyl-guanidine; involuntary weight loss disorders |
| 04/29/2008 | US7365068 Hepatitis C virus infections; -(3-cyclopropyl-4-(pentyloxy)phenyl)-3-nicotinoylthiourea;methyl 2-oxo-2-(5-((3-(4-(pentyloxy)-3-(trifluoromethyl)phenyl)thioureido)carbonyl)pyridin-2-ylamino)acetate |
| 04/29/2008 | US7365065 Antigonadotrophins; Breast and prostate cancer, endometriosis and benign prostate hyperplasia; regulation of fertility; in-vitro fertilisation; oral administration; inexpensive; 3-Amino-4-chloro-N-[4-chloro-5-(2,3-dihydro-benzo[1,4]oxazine-4-carbonyl)-thiophen-3-ylmethyl]-N-methyl-benzenesulfonamide |
| 04/29/2008 | CA2394037C New derivatives of benzene sulfonamide, their preparation process and pharmaceutical compositions that contain them |
| 04/29/2008 | CA2321188C Derivatives of azetidine and pyrrolidine |
| 04/29/2008 | CA2218887C Piperazino derivatives as neurokinin antagonists |
| 04/28/2008 | CA2666880A1 Organic compounds |
| 04/24/2008 | WO2008049047A2 Quinoline compounds |
| 04/24/2008 | WO2008048609A1 Biphenyl sulfonyl and phenyl-heteroaryl sulfonyl modulators of the histamine h3-receptor useful for the treatment of disorders related thereto |
| 04/24/2008 | WO2008047883A1 Piperazine-substituted benzothiophenes for treatment of mental disorders |
| 04/24/2008 | WO2008047224A1 Pyrazolyl-4-oxy-benzonitrile derivatives useful in treating endometriosis |
| 04/24/2008 | WO2008046756A1 Aminomethyl-2-imidazoles with affinity with the trace amine associated receptors |
| 04/24/2008 | WO2008046573A1 Substituted sulfonamide derivatives for use as bradykinin 1 receptor modulators |
| 04/24/2008 | WO2008024765A3 Therapeutic substituted thiazolidinones, oxazolidinones, and related compounds |
| 04/24/2008 | WO2008021518A3 Crystalline forms of tiagabine hydrochloride and processes for the preparation of amorphous tiagabine hydrochloride |
| 04/24/2008 | WO2008019967A3 Phenyl, pyridine and quinoline derivatives |
| 04/24/2008 | WO2008009415A3 4-heteroaryl-substituted 1-aminocyclohexane-1- and cyclohexene-1-derivatives having effects on the opiod receptor system |
| 04/24/2008 | US20080097109 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 04/24/2008 | US20080097103 Imidazole-2-thiones |
| 04/24/2008 | US20080097102 Aminotetralin-derived urea modulators of vanilloid vr1 receptor |
| 04/24/2008 | US20080097099 Insecticides; for human or veterinary medicine; preparing heterocyclic amide and imine derivatives |
| 04/24/2008 | US20080096949 Indazolyl-substituted pyrroline compounds as kinase inhibitors |
| 04/24/2008 | US20080096936 Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 04/24/2008 | US20080096913 peroxisome proliferator-activated receptor agonists; congestive heart failure, atherosclerosis, arteriosclerosis, obesity, hyperlipidemia, hypoalphalipoproteinemia, Syndrome X, diabetes, insulin resistance; 3-[5-Methoxy-1-(3-methoxy-benzyl)-1H-indol-3-yl]-propionic acid |
| 04/24/2008 | US20080096898 Organic Compounds |
| 04/24/2008 | US20080096889 Histone Deacetylases Inhibitors |
| 04/24/2008 | US20080096887 Benzene, Pyridine, and Pyridazine Derivatives |
| 04/24/2008 | US20080096885 Methyl 1-(2-fluorophenyl)-2-[(3-methoxy-2-phenylquinolin-4-yl)carbonyl]hydrazinecarboxylate; schizophrenia |
| 04/24/2008 | US20080096873 New compounds |
| 04/24/2008 | CA2666508A1 Quinoline compounds |
| 04/24/2008 | CA2666406A1 Substituted sulfonamide derivatives for use as bradykinin 1 receptor modulators |
| 04/24/2008 | CA2665255A1 Aminomethyl-2-imidazoles with affinity with the trace amine associated receptors |
| 04/24/2008 | CA2665204A1 Biphenyl sulfonyl and phenyl-heteroaryl sulfonyl modulators of the histamine h3-receptor useful for the treatment of disorders related thereto |
| 04/23/2008 | EP1914233A1 Peripherally-selective inhibitors of dopamine-b-hydroxylase and method of their preparation |
| 04/23/2008 | EP1912972A1 Substituted imidazole compounds as ksp inhibitors |
| 04/23/2008 | EP1912970A2 Acyltryptophanols for fertility control |
| 04/23/2008 | EP1912662A2 Peptide deformylase inhibitors |
| 04/23/2008 | EP1635828B1 4-(2-phenyloxyphenyl)-piperidine or -1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors |
| 04/23/2008 | EP1474145B1 Quinoline derivatives as npy antagonists |
| 04/23/2008 | EP1387836B1 Phthalazine derivatives with angiogenesis inhibiting activity |
| 04/23/2008 | EP0998459B1 Pyridine derivatives |
| 04/23/2008 | CN101166737A Phosphodiesterase 4 inhibitors |
| 04/23/2008 | CN101166734A Novel aminopyridine compounds having Syk inhibitory activity |
| 04/23/2008 | CN101166731A Herbicidally active phenylsulphonyl-urea |
| 04/23/2008 | CN101166730A Cinnoline compounds and their use as liver X receptor modilators |
| 04/23/2008 | CN101166726A Quinoline and quinoxaline derivatives as inhibitors of kinase enzymatic activity |
| 04/23/2008 | CN101166725A Pyridylacetic acid compound |
| 04/23/2008 | CN100383140C Isoquinoline derivatives having kinasae inhibitory activity and drugs containing the same |
| 04/23/2008 | CN100383132C Azoles as malonyl-COA decarboxylase inhibitors useful as metabolic modulators |
| 04/23/2008 | CN100383124C Quinoline derivatives as NPY antagonists |
| 04/22/2008 | US7361687 Antagonists of the B2 receptor of bradykinin; analgesics; hyperalgesia and major algesia; cancer; nontoxic; industrial scale; 5-[[(2,4-dichloro-3-methylphenyl)sulphonyl]methylamino]-N-[[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]methyl]-N-methyl-pentanamide |
| 04/22/2008 | US7361679 Integrin VLA-4 ( alpha 4 beta 1) and/or integrin LPAM-1 ( alpha 4 beta 7) antagonists, cell adhesion inhibitor; bioavailability, oral administration;treating inflammatory diseases; e.g. 3-[2-(2,6-dichlorobenzoylamino)pyrid-5-yl]-2-{3-[(2,2-dimethylpropionyl)isobutylamino]-4-methoxyphenyl}propionic acid |
| 04/22/2008 | US7361670 Amide derivatives as NMDA receptor antagonists |
| 04/22/2008 | US7361666 Ligands for cellular receptors, including opiate receptors; side effect reduction; base structure is a saturated nitrogen-containing ring substituted with a tertiary amide that is N-substituted with an arylalkyl group |
| 04/22/2008 | US7361665 For therapy of inflammatory disease, autoimmune disease, destructive bone disorder, proliferative disorder, infectious disease, neurodegenerative disease, allergy, reperfusion/ischemia in stroke, heart attack, hypoxia |
| 04/22/2008 | US7361663 N-acylpyrrolidin-2-ylalkylbenzamidine derivatives as inhibitors of factor Xa |
| 04/22/2008 | US7361648 1-(4-{ethyl-[2-(4-methanesulfonylphenyl)-1-methylethyl]amino}butyl)-4-methanesulfonyl-[1,4]diazepan-2-one; repiratory system disorders: asthma and chronic obstructive pulmonary disease; nervous system, muscular,urogenital, gastrointestinal disorders; antiallergens; side effect reduction |
| 04/22/2008 | US7361449 Specific dye compound, optical information recording medium comprising specific dye, and information recording method using this optical information recording medium |
| 04/22/2008 | CA2210693C Pyrazol-4-yl-benzoyl derivatives and their use as herbicides |
| 04/17/2008 | WO2008045668A1 Heterocyclic derived metalloprotease inhibitors |
| 04/17/2008 | WO2008045564A2 Carboxamide compounds and their use as antagonists of the chemokine ccr2 receptor |
| 04/17/2008 | WO2008045484A1 N-aryl pyrazole compounds for use against diabetes |
| 04/17/2008 | WO2008044767A1 Aromatic amine derivative and use thereof |
| 04/17/2008 | WO2008044700A1 GSK-3β INHIBITOR |
| 04/17/2008 | WO2008044217A2 2-aminocarbonyl-pyridine derivatives |
| 04/17/2008 | WO2008043791A2 Thiophene derivatives for treating hepatitis c |
| 04/17/2008 | WO2008043789A1 Novel compounds |
| 04/17/2008 | WO2008043788A2 Novel compounds |
| 04/17/2008 | WO2008043544A1 Sulfonamide substituted pyrazoline compounds, their preparation and use as cb1 modulators |
| 04/17/2008 | WO2008027542A3 5-substituted isoindoline compounds |
| 04/17/2008 | WO2008021933A3 N-aryl or n-heteroaryl pyrazolidine and pyrazolidinone derivatives as prostaglandine receptor inhibitors |
| 04/17/2008 | WO2008011117A3 Antiviral protease inhibitors |
| 04/17/2008 | WO2007146323A3 Substituted cyanopyridines as protein kinase inhibitors |
| 04/17/2008 | WO2007085895A3 Fap inhibitors |
| 04/17/2008 | WO2005047266A9 Aryl imidazoles and their use as anti-cancer agents |
| 04/17/2008 | US20080090996 Thrombopoietin mimetics |
| 04/17/2008 | US20080090875 Analgesics, antipyretics, antiinflammatory agents; 4-(4-chlorophenyl)-5-(4-methanesulfonylphenyl)-1,2-dihydropyrazole-3-thione for example; cyclooxygenase-2 (COX-2) inhibitors; side effect reduction |
| 04/17/2008 | US20080090854 Cxcr2 inhibitors |
| 04/17/2008 | US20080090845 Haloalkyl-substituted pyrimidinone derivatives |
| 04/17/2008 | US20080090816 Anti-infective biaryl compounds |
| 04/17/2008 | US20080090810 Thiophene compounds |
| 04/17/2008 | US20080090797 tert-Butyl[3-(4-phenyloxazolidin-2-on-3-yl)-4-(2-styryl)azetidin-2-on-1-yl]acetate; known as synthetic intermediates for the preparation of beta -lactam antibiotics; diuretic |